Aaaaaaaand another one. Admittedly this one isn't too bad. Revenue is low and not much cash in the bank so not as though its deceiving shareholders. Need good replacement
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025